UBS Group
CURE icon

UBS Group’s Direxion Daily Healthcare Bull 3X ETF CURE Stock Holding History

UBS Group’s Portfolio CURE Stock Details CURE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-418
Closed -$46.6K – 10599
2025
Q4 		$46.6K Buy
418
+161
+63% +$16.5K ﹤0.01% 7261
2025
Q3 		$21.5K Buy
257
+256
+25,600% +$19.9K ﹤0.01% 8106
2025
Q2 		$79 Sell
1
-5,152
-100% -$416K ﹤0.01% 10019
2025
Q1 		$549K Buy
5,153
+4,844
+1,568% +$515K ﹤0.01% 5779
2024
Q4 		$28.5K Buy
+309
New +$34.8K ﹤0.01% 7642
2024
Q3 		– Sell
-1,075
Closed -$126K – 9573
2024
Q2 		$126K Buy
+1,075
New +$121K ﹤0.01% 6006
2024
Q1 		– Sell
-203
Closed -$20.7K – 9411
2023
Q4 		$20.7K Sell
203
-316
-61% -$28.3K ﹤0.01% 7086
2023
Q3 		$45.9K Buy
519
+504
+3,360% +$49.6K ﹤0.01% 6341
2023
Q2 		$1.5K Buy
+15
New +$1.49K ﹤0.01% 7905
2022
Q4 		– Sell
-137
Closed -$12K – 10776
2022
Q3 		$12K Buy
+137
New +$14.1K ﹤0.01% 8152
2021
Q4 		– Sell
-256
Closed -$28K – 10317
2021
Q3 		$28K Buy
256
+56
+28% +$6.74K ﹤0.01% 6812
2021
Q2 		$21K Sell
200
-1,300
-87% -$125K ﹤0.01% 7272
2021
Q1 		$125K Sell
1,500
-467
-24% -$37.7K ﹤0.01% 5786
2020
Q4 		$152K Sell
1,967
-2,233
-53% -$154K ﹤0.01% 5417
2020
Q3 		$265K Sell
4,200
-2,349
-36% -$147K ﹤0.01% 4623
2020
Q2 		$356K Buy
6,549
+4,983
+318% +$264K ﹤0.01% 4392
2020
Q1 		$62K Sell
1,566
-1,320
-46% -$83.2K ﹤0.01% 5654
2019
Q4 		$213K Sell
2,886
-442
-13% -$27K ﹤0.01% 5561
2019
Q3 		$168K Buy
3,328
+545
+20% +$28.9K ﹤0.01% 5381
2019
Q2 		$156K Buy
2,783
+2,201
+378% +$113K ﹤0.01% 5078
2019
Q1 		$32K Sell
582
-1,535
-73% -$81.6K ﹤0.01% 5888
2018
Q4 		$101K Buy
2,117
+993
+88% +$55.8K ﹤0.01% 5533
2018
Q3 		$75K Sell
1,124
-2,598
-70% -$149K ﹤0.01% 5827
2018
Q2 		$169K Buy
3,722
+739
+25% +$33.1K ﹤0.01% 5079
2018
Q1 		$128K Buy
+2,983
New +$150K ﹤0.01% 5070
2017
Q3 		– Sell
-2,030
Closed -$85K – 7753
2017
Q2 		$85K Sell
2,030
-9,805
-83% -$363K ﹤0.01% 5273
2017
Q1 		$408K Buy
11,835
+7,519
+174% +$244K ﹤0.01% 4186
2016
Q4 		$119K Sell
4,316
-5,440
-56% -$153K ﹤0.01% 5168
2016
Q3 		$311K Buy
+9,756
New +$332K ﹤0.01% 4236
2016
Q1 		– Sell
-4,569
Closed -$153K – 7709
2015
Q4 		$153K Buy
+4,569
New +$145K ﹤0.01% 4886
2015
Q2 		– Sell
-6,725
Closed -$198K – 8535
2015
Q1 		$198K Buy
+6,725
New +$188K ﹤0.01% 4885

Other funds holding CURE

Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
GS
GTS Securities New York $2.83B AUM 21.76% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
TCM
Traynor Capital Management Malvern, Pennsylvania $2.18B AUM 62.36% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
SF
Summit Financial Parsippany, New Jersey $7.85B AUM 20.99% 1-Year Est. Return
OBWG
Onyx Bridge Wealth Group Tarrytown, New York $1.11B AUM 24.65% 1-Year Est. Return
PWPS
Pinnacle Wealth Planning Services Mansfield, Ohio $968M AUM 19.1% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

UBS Group's CURE Position: Q1 2026 in Review

UBS Group sold out of Direxion Daily Healthcare Bull 3X ETF (CURE) in Q1 2026, closing a stake of 418 shares — an estimated $46.6K sold.

UBS Group first reported a position in CURE in Q1 2015 and held it in 31 quarters. The position peaked at $549K in Q1 2025. 15 funds tracked by Wall St. Rank hold CURE as of Q1 2026.

  • UBS Group reported no remaining Direxion Daily Healthcare Bull 3X ETF position as of Q1 2026 after selling out during the quarter.
  • UBS Group sold 418 Direxion Daily Healthcare Bull 3X ETF shares in Q1 2026, an estimated $46.6K.
  • UBS Group first reported a position in Direxion Daily Healthcare Bull 3X ETF in Q1 2015 and held it in 31 quarters.
  • UBS Group's Direxion Daily Healthcare Bull 3X ETF position peaked at $549K in Q1 2025.
  • 15 funds tracked by Wall St. Rank held Direxion Daily Healthcare Bull 3X ETF as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.